Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Boehringer Ingelheim
Farmers Insurance
Fuji
Cantor Fitzgerald
Cerilliant
Dow
Colorcon
AstraZeneca

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 010379

« Back to Dashboard

NDA 010379 describes CYTOMEL, which is a drug marketed by King Pharms and is included in one NDA. It is available from two suppliers. Additional details are available on the CYTOMEL profile page.

The generic ingredient in CYTOMEL is liothyronine sodium. There are four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
Summary for 010379
Tradename:CYTOMEL
Applicant:King Pharms
Ingredient:liothyronine sodium
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
Formulation / Manufacturing:see details
Pharmacology for NDA: 010379
Ingredient-typeTriiodothyronine
Suppliers and Packaging for NDA: 010379
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYTOMEL liothyronine sodium TABLET;ORAL 010379 NDA Physicians Total Care, Inc. 54868-1750 54868-1750-2 10 TABLET in 1 BOTTLE, PLASTIC (54868-1750-2)
CYTOMEL liothyronine sodium TABLET;ORAL 010379 NDA Physicians Total Care, Inc. 54868-1750 54868-1750-1 30 TABLET in 1 BOTTLE, PLASTIC (54868-1750-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.005MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.025MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.05MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
Farmers Insurance
Teva
Cipla
Johnson and Johnson
Daiichi Sankyo
Dow
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot